The impaired gene expression of adenosine monophosphate-activated kinase (AMPK), a key metabolic enzyme in leukocytes of newly diagnosed rheumatoid arthritis patients - Samimi, Zahra; Kardideh, Bahareh; Zafari, Parisa; Bahrehmand, Fariborz; Roghani, Seyed Askar; Taghadosi, Mahdi (Molecular biology reports, 2019)
Keywords: Adenosine; Adenosine kinase; AMP; AMP-activated protein kinase; AMP-Activated Protein Kinases - genetics; Animal Anatomy; Animal Biochemistry; Antirheumatic Agents - pharmacology; Antirheumatic Agents - therapeutic use; Arthritis, Rheumatoid - diagnosis; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - genetics; Autoimmune diseases; Biomedical and Life Sciences; blood; Case-Control Studies; disease severity; Down-Regulation - drug effects; drugs; Enzyme-linked immunosorbent assay; Female; Gene expression; Histology; Homeostasis; Humans; Immune system; Inflammation; Interleukin 10; Interleukin-10 - blood; Kinases; Leukocytes; Leukocytes - metabolism; Life Sciences; Male; Middle Aged; Morphology; Original Article; Pathogenesis; Peripheral blood; Plasma levels; Protein kinase; quantitative polymerase chain reaction; Rheumatoid arthritis; therapeutics; Transforming Growth Factor beta1 - blood; Transforming growth factor-b1; AMPK; TGF-β1; Inflammation; Rheumatoid arthritis; IL-10; Cytokine